In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response

Abstract Clodronate is a bisphosphonate agent commonly used as anti-osteoporotic drug. Throughout its use, additional anti-inflammatory and analgesic properties have been reported, although the benefits described in the literature could not solely relate to their inhibition of bone resorption. Thus,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rosangela Montanaro, Alessio D’Addona, Andrea Izzo, Carlo Ruosi, Vincenzo Brancaleone
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9d63c65bd58c4f1e8a98992d463f86f9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9d63c65bd58c4f1e8a98992d463f86f9
record_format dspace
spelling oai:doaj.org-article:9d63c65bd58c4f1e8a98992d463f86f92021-12-02T17:55:03ZIn vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response10.1038/s41598-021-94228-y2045-2322https://doaj.org/article/9d63c65bd58c4f1e8a98992d463f86f92021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94228-yhttps://doaj.org/toc/2045-2322Abstract Clodronate is a bisphosphonate agent commonly used as anti-osteoporotic drug. Throughout its use, additional anti-inflammatory and analgesic properties have been reported, although the benefits described in the literature could not solely relate to their inhibition of bone resorption. Thus, the purpose of our in vitro study is to investigate whether there are underlying mechanisms explaining the anti-inflammatory effect of clodronate and possibly involving hydrogen sulphide (H2S). Immortalised fibroblast-like synoviocyte cells (K4IM) were cultured and treated with clodronate in presence of TNF-α. Clodronate significantly modulated iNOS expression elicited by TNF-α. Inflammatory markers induced by TNF-α, including IL-1, IL-6, MCP-1 and RANTES, were also suppressed following administration of clodronate. Furthermore, the reduction in enzymatic biosynthesis of CSE-derived H2S, together with the reduction in CSE expression associated with TNF-α treatment, was reverted by clodronate, thus rescuing endogenous H2S pathway activity. Clodronate displays antinflammatory properties through the modulation of H2S pathway and cytokines levels, thus assuring the control of the inflammatory state. Although further investigation is needed to stress out how clodronate exerts its control on H2S pathway, here we showed for the first the involvement of H2S in the additive beneficial effects observed following clodronate therapy.Rosangela MontanaroAlessio D’AddonaAndrea IzzoCarlo RuosiVincenzo BrancaleoneNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Rosangela Montanaro
Alessio D’Addona
Andrea Izzo
Carlo Ruosi
Vincenzo Brancaleone
In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response
description Abstract Clodronate is a bisphosphonate agent commonly used as anti-osteoporotic drug. Throughout its use, additional anti-inflammatory and analgesic properties have been reported, although the benefits described in the literature could not solely relate to their inhibition of bone resorption. Thus, the purpose of our in vitro study is to investigate whether there are underlying mechanisms explaining the anti-inflammatory effect of clodronate and possibly involving hydrogen sulphide (H2S). Immortalised fibroblast-like synoviocyte cells (K4IM) were cultured and treated with clodronate in presence of TNF-α. Clodronate significantly modulated iNOS expression elicited by TNF-α. Inflammatory markers induced by TNF-α, including IL-1, IL-6, MCP-1 and RANTES, were also suppressed following administration of clodronate. Furthermore, the reduction in enzymatic biosynthesis of CSE-derived H2S, together with the reduction in CSE expression associated with TNF-α treatment, was reverted by clodronate, thus rescuing endogenous H2S pathway activity. Clodronate displays antinflammatory properties through the modulation of H2S pathway and cytokines levels, thus assuring the control of the inflammatory state. Although further investigation is needed to stress out how clodronate exerts its control on H2S pathway, here we showed for the first the involvement of H2S in the additive beneficial effects observed following clodronate therapy.
format article
author Rosangela Montanaro
Alessio D’Addona
Andrea Izzo
Carlo Ruosi
Vincenzo Brancaleone
author_facet Rosangela Montanaro
Alessio D’Addona
Andrea Izzo
Carlo Ruosi
Vincenzo Brancaleone
author_sort Rosangela Montanaro
title In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response
title_short In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response
title_full In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response
title_fullStr In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response
title_full_unstemmed In vitro evidence for the involvement of H2S pathway in the effect of clodronate during inflammatory response
title_sort in vitro evidence for the involvement of h2s pathway in the effect of clodronate during inflammatory response
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9d63c65bd58c4f1e8a98992d463f86f9
work_keys_str_mv AT rosangelamontanaro invitroevidencefortheinvolvementofh2spathwayintheeffectofclodronateduringinflammatoryresponse
AT alessiodaddona invitroevidencefortheinvolvementofh2spathwayintheeffectofclodronateduringinflammatoryresponse
AT andreaizzo invitroevidencefortheinvolvementofh2spathwayintheeffectofclodronateduringinflammatoryresponse
AT carloruosi invitroevidencefortheinvolvementofh2spathwayintheeffectofclodronateduringinflammatoryresponse
AT vincenzobrancaleone invitroevidencefortheinvolvementofh2spathwayintheeffectofclodronateduringinflammatoryresponse
_version_ 1718379182168211456